Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CTX130 |
Synonyms | |
Therapy Description |
CTX130 are allogeneic T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD70, which recognize and bind to CD70-expressing tumor cells, potentially resulting in antitumor activity (Cancer Res 2020;80 (16 Suppl):Abstract nr 6595). |